Charles Schwab’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-30,113
| Closed | -$1.59M | – | 3425 |
|
|
2020
Q3 | $1.59M | Sell |
30,113
-591
| -2% | -$36.5K | ﹤0.01% | 2571 |
|
|
2020
Q2 | $1.88M | Buy |
30,704
+1,586
| +5% | +$91.7K | ﹤0.01% | 2449 |
|
|
2020
Q1 | $1.65M | Sell |
29,118
-25,016
| -46% | -$1.43M | ﹤0.01% | 2337 |
|
|
2019
Q4 | $3.08M | Buy |
54,134
+5,541
| +11% | +$294K | ﹤0.01% | 2263 |
|
|
2019
Q3 | $2.6M | Buy |
48,593
+6,476
| +15% | +$377K | ﹤0.01% | 2296 |
|
|
2019
Q2 | $2.52M | Buy |
42,117
+1,389
| +3% | +$87.4K | ﹤0.01% | 2291 |
|
|
2019
Q1 | $2.54M | Sell |
40,728
-5,516
| -12% | -$365K | ﹤0.01% | 2283 |
|
|
2018
Q4 | $2.8M | Hold |
46,244
| – | – | ﹤0.01% | 2196 |
|
|
2018
Q3 | $2.71M | Sell |
46,244
-182
| -0.4% | -$9.29K | ﹤0.01% | 2332 |
|
|
2018
Q2 | $2.08M | Buy |
46,426
+3,514
| +8% | +$151K | ﹤0.01% | 2366 |
|
|
2018
Q1 | $1.9M | Hold |
42,912
| – | – | ﹤0.01% | 2352 |
|
|
2017
Q4 | $1.86M | Buy |
42,912
+1,100
| +3% | +$49.4K | ﹤0.01% | 2336 |
|
|
2017
Q3 | $1.95M | Buy |
41,812
+3,541
| +9% | +$170K | ﹤0.01% | 2299 |
|
|
2017
Q2 | $1.9M | Hold |
38,271
| – | – | ﹤0.01% | 2238 |
|
|
2017
Q1 | $2.1M | Sell |
38,271
-4,739
| -11% | -$251K | ﹤0.01% | 2183 |
|
|
2016
Q4 | $2.4M | Sell |
43,010
-1,700
| -4% | -$81.7K | ﹤0.01% | 2099 |
|
|
2016
Q3 | $2.04M | Hold |
44,710
| – | – | ﹤0.01% | 2120 |
|
|
2016
Q2 | $1.79M | Hold |
44,710
| – | – | ﹤0.01% | 2133 |
|
|
2016
Q1 | $1.56M | Hold |
44,710
| – | – | ﹤0.01% | 2177 |
|
|
2015
Q4 | $1.92M | Hold |
44,710
| – | – | ﹤0.01% | 2103 |
|
|
2015
Q3 | $1.95M | Buy |
44,710
+2,700
| +6% | +$146K | ﹤0.01% | 2078 |
|
|
2015
Q2 | $2.17M | Sell |
42,010
-7,405
| -15% | -$316K | ﹤0.01% | 2039 |
|
|
2015
Q1 | $1.94M | Hold |
49,415
| – | – | ﹤0.01% | 2072 |
|
|
2014
Q4 | $1.91M | Hold |
49,415
| – | – | ﹤0.01% | 2037 |
|
|
2014
Q3 | $1.75M | Buy |
49,415
+7,875
| +19% | +$231K | ﹤0.01% | 2042 |
|
|
2014
Q2 | $1.12M | Buy |
+41,540
| New | +$1.08M | ﹤0.01% | 2263 |
|
Other funds holding BSTC
Charles Schwab's BSTC Position: Q4 2020 in Review
Charles Schwab sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 30,113 shares — an estimated $1.59M sold.
Charles Schwab first reported a position in BSTC in Q2 2014 and held it in 26 quarters. The position peaked at $3.08M in Q4 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Charles Schwab reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Charles Schwab sold 30,113 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.59M.
- Charles Schwab first reported a position in BioSpecifics Technologies Corp. in Q2 2014 and held it in 26 quarters.
- Charles Schwab's BioSpecifics Technologies Corp. position peaked at $3.08M in Q4 2019.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Charles Schwab's 13F filing for Q4 2020, filed 16 Feb 2021.